title: Management of fungal lung disease in the immunocompromised.
abstract: Pulmonary mycoses are among the most feared infections encountered in immunocompromised patients. The problem is amplified by the increasing numbers of chronically immunocompromised patients that have substantially increased both the prevalence and clinical severity of infections caused by fungi. Moreover, fungal infections in this patient population pose challenges in diagnosis and management. Fortunately, recent advances in diagnostics and antifungal therapy, and their direct application to specific diseases, provide important new approaches to this complex and often seriously ill patient population. In this article we review the commonly occurring pulmonary fungal infections in the immunocompromised population with a particular focus on their management.
authors.affiliation: Snyder Institute for Infection, Inflammation and Immunity, University of Calgary, Alberta, Canada.
authors.forename: Anowara
authors.initials: A
authors.lastname: Islam
authors.forename: Christopher H
authors.initials: CH
authors.lastname: Mody
mesh_terms: D000818:Animals; D000935:Antifungal Agents / Q000627:therapeutic use*; D006801:Humans; D016867:Immunocompromised Host; D008172:Lung Diseases, Fungal / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D015995:Prevalence; D012720:Severity of Illness Index
chemical_list: D000935:Antifungal Agents